Prof Mark Lawler, Chair, Translational Cancer Genomics, Centre for Cancer Research and Cell Biology, Queen’s University Belfast highlights the need for collaboration between stakeholders for development of precision medicine modules, at the session on "Life sciences & future healthcare" at India - UK Tech Summit held from 7-9 November 2016 in New Delhi.